Longaeva Partners’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
Other funds holding ENTA
Longaeva Partners's ENTA Position: Q3 2026 in Review
Longaeva Partners opened a new position in Enanta Pharmaceuticals (ENTA) in Q3 2026: 226,587 shares worth $2.99M. The stake represents 0.06% of the portfolio and ranks #218 among its holdings.
127 funds tracked by Wall St. Rank hold ENTA as of Q3 2026.
- Longaeva Partners held 226,587 shares of Enanta Pharmaceuticals worth $2.99M as of Q3 2026.
- Enanta Pharmaceuticals was a new Longaeva Partners position in Q3 2026.
- Enanta Pharmaceuticals made up 0.06% of Longaeva Partners's portfolio in Q3 2026, its #218 holding.
- 127 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q3 2026.
Based on Longaeva Partners's 13F filing for Q3 2026, filed 16 Nov 2026.